Fibromyalgia Subsets
Devin J. Starlanyl
6/04
Fibromyalgia (FM) is
not homogenous. As I. Jon Russell, MD, PhD, editor of Journal of
Musculoskeletal Pain, said to me, "Fibromyalgia is not an 'it'. It's
a 'they'." Research shows that this is true (1, 2, 3, 4, 5, 6).
I believe that the key to treating FM, like CMPD, is to identify and
control the initiating and perpetuating factors as much as possible.
I also believe that identifying subsets are a key to this process.
Years ago, my friend J. B.
Eisinger, French clinician and researcher, contacted me with an exciting
proposal. He planned to organize a team to define meaningful clinical
subsets of FM. These subsets would be categorized by perpetuating
factors, cause (initiating factors), and symptoms (presenting factors).
Patients would be coded as to age, gender, duration and seriousness of
symptoms. For research purposes, after tabulating the coding, the names could
then be omitted, keeping the patients anonymous.
I was asked to be part of the team.
The result was a medical journal article
that would be especially valuable for FM researchers (7).
The protocol was published in French. Using the translated format
of the protocol for anonymous clinical study for researchers, I have modified
it into a protocol for identification of FM subsets for clinicians, with Dr.
Eisinger's approval. I hope
clinicians will find it helpful. Devin J. Starlanyl
Bibliography
1. |
Walen HR, Cronan TA,
Server ER et al. 2002. Subgroups of fibromyalgia patients:
evidence for heterogeneity and an examination of differential effects
following a community-based intervention. J Musculoskel Pain
10(3):9-32. |
2. |
Bennett RM. 2002.
Adult growth hormone deficiency in patients with fibromyalgia. Curr
Rheumatol Rep 4(4):306-12. |
3. |
Smith JD, Terpening CM,
Schmidt SO et al. 2001. Relief of fibromyalgia symptoms
following discontinuation of dietary excitotoxins. Ann
Pharmacother 35(6):702-706. |
4. |
Giesecke T, Williams DA,
Harris RE et al. 2003. Subgrouping of fibromyalgia patients on
the basis of pressure-pain thresholds and psychological factors.
Arthritis Rheum 48 (10):2916-2922. |
5. |
Gursoy S. 2002.
Absence of association of the serotonin transporter gene polymorphism
with the mentally healthy subset of fibromyalgia patients. Clin
Rheumatol 21(3):194-195. |
6. |
Stratz T, Schochat T,
Farber L, Schweiger C, Muller W.
Are there subgroups in fibromyalgia? J Musculoskel
Pain3 (suppl 1) : 15 [Abstract]. |
7. |
Eisinger, J, D Starlanyl,
F Blotman, L Bueno, E Houvenagle, R Juvin, P Kaminsky, K Lawson, X Le
Loet, J Lowe, P Manesse, K Mechtouof, N Memran, W Muller, M Nicollet,
JC Perragut, A Plantamura, JP Poinsignon, E Reig, R Ruiz Lopez, KL
Schmitt, P Sichere, J Teitelbaum, R Treves, H Zakarian.
2000. [Protocole d'informations anonyme sur les
fibromyalgiques.] Medicine du sud-est Lyon Mediterranee
Medical. 1: 9-11. [French] |
Protocol
for Identification of Fibromyalgia Subsets
1. |
General Information |
|
|
|
Patient Name _______________________________ |
Date ______________ |
|
This
form was filled out by: _______________________________________ |
|
o
the patient alone |
o
assisted by a doctor |
|
The diagnosis
was made by: ______________________________________ |
|
o
a generalist |
o
a rheumatologist |
o another specialist |
|
Type of pain: |
|
|
|
o
diffuse |
o
persistent |
o
enigmatic |
Number of Tender points
= _____ |
2. |
General Coding |
|
|
|
o
Male |
o
Female |
Age = ______ |
|
Exercise/Diet
|
|
Excessive consumption of
caffeine, alcohol, carbohydrates, tobacco?
|
|
Family clustering (members
of family with FMS or FMS-like symptoms)?
|
|
Physical
Activity: |
|
|
|
|
o
None |
o
1 Hour a Day |
o
2 Hours |
o
2 Hours and Sport |
o
Athlete |
|
Duration and
severity (social, professional and on life quality repercussion): |
|
1
- Less than 5 years
|
1
- Moderate (normal activity) |
1
- Life quality = good |
|
2
- More than 5 years |
2
- Severe (frequent sick leave) |
2
- life quality = moderate |
|
3
- More than 10
years |
3
- Very severe (one year sick leave) |
3
- life quality = bad |
|
4
- More than 15
years |
4
- disabling
(compulsory help) |
4
- life quality = very bad |
Symptoms,
Perpetuating Factors and Possible Etiologies:
Allergies (asthma, vasomotor rhinitis; urticaria, ocular, chronic sinusitis)
Bruxism,
Temporomandibular Dysfunction
Circulatory
Dysfunction (Raynaud's Syndrome, migraine)
Digestion
(GERDS, IBS)
Endocrinology/Metabolism
(malnutrition, obesity, insulin resistance, Metabolic Syndrome)
Fatigue
(distinct physical fatigue, mental fatigue/loss of memory and/or focus, CFIDS)
Gynecology
(Premenstrual Syndrome, untreated menopause, vaginismus, vulvar pain)
Hypothyroidism:
Treated with T4 (equilibrated/not) or other hormones (equilibrated/not)
Infections
(chronic bacterial, fungal, viral, protozoal)
Juvenile
(symptoms appeared at puberty; prepuberty)
Cancer
(treated/not treated with recent chemotherapy, other treatment)
Systemic
lupus erythematosis, polyarthritis rheumatica, osteoarthritis
Medicamentosus
(Possible onset due to beta blockers, other medications, toxins, pollutants)
Neurological
(carpal tunnel, MS, NMH)
Ocular
(cataract, glaucoma, Sicca Syndrome)
Psychiatric
(depression intrinsic/secondary, anxiety, panic attacks, PTSD, ADHD, OC)
Quantification
of Pain (spontaneous, moderate, major, hyperalgesia, allodynia)
Regional
pain (myofascial trigger points latent/active, local/regional, multiple
regions; chronic myofascial pain/lasting trigger points in at least three
quadrants with spinal involvement, myofascial nerve/lymph/blood vessel
entrapment)
Sleep
disorders (severe insomnia, sleep apnea central/congestive, narcolepsy, PLMS,
RLS
Trauma
(spinal, peripheral)
Urological
(irritable bladder, voiding dysfunction)
Dysautonomia
(orthostatic hypotention, tachychardia, palpitations)
Other
causes:
Other
symptoms:
Co-existing
conditions: (diabetes,
hypertension)
Other
treatments and medications linked with FM (analgesics, antidepressants...)
Comments:
Back to
Top
Most
books on our
site are available from:

Why
buy at Amazon through links from our website?
|